Naimish Patel, Chief Medical Officer at CRISPR Therapeutics AG (CRSP), sold 7,864 shares at $35.94 ($283K) on 2025-05-29, disclosed to the SEC on 2025-05-30.
Open-market sale of $283k CRSP by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.94 | 3,932 | $141K | 50.0% |
| 2 | $35.94 | 3,932 | $141K | 50.0% |
| Total | $35.94 avg | 7,864 | $283K | 100% |
| Filing → |
| CRSP | BUY | 2026-01-27 | $50K | — | Filing → |